Stocks that Could Benefit from a Study of THCV

THCV, or tetrahydrocannabivarin may have the potential to help with energy, focus/attention, and eve appetite, weight/BMI. In fact, in a study of 900 adults aged 21 and older in the U.S., InMed Pharmaceuticals Inc.’s (NASDAQ: INM) subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle Science, Inc.’s Radicle Energy rare cannabinoid program.  Tetrahydrocannabivarin, … Continue reading Stocks that Could Benefit from a Study of THCV

Catalysts Driving a $165.7 Billion CBD Opportunity

The CBD infused product market could balloon to $165.7 billion, according to Meticulous Research at a CAGR of 48.1%.  That’s already creating sizable opportunity for companies such as Pure Extracts Technologies Corp. (CSE:PULL)(OTC:PRXTF)(XFRA:A2QJAJ), Canopy Growth Corporation (NASDAQ:CGC)(TSX:WEED), Tilray Inc. (NASDAQ:TLRY), Charlotte’s Web Holdings Inc. (TSX:CWEB)(OTC:CWBHF), and cbdMD Inc. (NYSE:YCBD). “CBD-infused products are becoming increasingly popular. … Continue reading Catalysts Driving a $165.7 Billion CBD Opportunity